| 2024 | Aggressive Local Ablative Radiotherapy Mitigates Progression Risk in Oligometastatic Lung Adenocarcinoma
| CANCER RESEARCH AND TREATMENT |
| 2023 | Risk of on-treatment lymphopenia is associated with treatment outcome and efficacy of consolidation immunotherapy in patients with non-small cell lung cancer treated with concurrent chemoradiotherapy | RADIOTHERAPY AND ONCOLOGY |
| 2023 | Carbon Ion Radiotherapy: An Evidence-Based Review and Summary Recommendations of Clinical Outcomes for Skull-Base Chordomas and Chondrosarcomas
| CANCERS |
| 2023 | Prognosis prediction for glioblastoma multiforme patients using machine learning approaches: Development of the clinically applicable model | RADIOTHERAPY AND ONCOLOGY |
| 2023 | Sinoatrial Node Radiation Dose and Atrial Fibrillation in Patients With Lung Cancer-Reply | JAMA ONCOLOGY |
| 2023 | Clinical Outcomes of Thymic Carcinoma: The Role of Radiotherapy Combined with Multimodal Treatments
| CANCERS |
| 2023 | Association of T Cell Senescence with Radiation Pneumonitis in Patients with Non-small Cell Lung Cancer | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
| 2022 | A Multicenter Two-arm, Phase II Trial Assessing the Safety and Efficacy of First-line Lazertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR-mutant Non-small Cell Lung Cancer (ABLATE, KCSG-LU21-11) | CLINICAL LUNG CANCER |
| 2022 | Treatment outcomes and radiotherapy deintensification strategies in human papillomavirus-associated tonsil cancer
| RADIATION ONCOLOGY |
| 2022 | A Comparison of 2 Disease Burden Assessment Methods (3D Volume Versus the Number of Lesions) for Prognostication of Survival in Metastatic Melanoma: Implications for the Characterization of Oligometastatic Disease | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
| 2022 | Association of Sinoatrial Node Radiation Dose With Atrial Fibrillation and Mortality in Patients With Lung Cancer | JAMA ONCOLOGY |
| 2022 | First-line pembrolizumab versus dabrafenib/trametinib treatment for BRAF V600-mutant advanced melanoma | JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY |
| 2022 | Role of Local Treatment for Oligometastasis: A Comparability-Based Meta-Analysis
| CANCER RESEARCH AND TREATMENT |
| 2022 | Automated coronary artery calcium scoring in patients with breast cancer to assess the risk of heart disease following adjuvant radiation therapy
| BREAST |
| 2022 | Patterns of recurrence according to the extent of resection in patients with IDH-wild-type glioblastoma: a retrospective study | JOURNAL OF NEUROSURGERY |
| 2022 | Risk of Diabetes Mellitus after Radiotherapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
| CANCERS |
| 2022 | Dynamics of Circulating Immune Cells During Chemoradiotherapy in Patients with Non-Small Cell Lung Cancer Support Earlier Administration of Anti-PD-1/PD-L1 Therapy | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
| 2022 | Prognostic impact of neutrophilia and lymphopenia on survival in anal cancer treated with definitive concurrent chemoradiotherapy: a retrospective multicenter study | INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY |
| 2022 | Increased Radiosensitivity of Solid Tumors Harboring ATM and BRCA1/2 Mutations
| CANCER RESEARCH AND TREATMENT |
| 2022 | Predicting treatment outcomes using 18 F-FDG PET biomarkers in patients with non-small-cell lung cancer receiving chemoimmunotherapy
| THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY |
| 2022 | A novel gene signature associated with poor response to chemoradiotherapy in patients with locally advanced cervical cancer
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2021 | Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancer
| JOURNAL FOR IMMUNOTHERAPY OF CANCER |
| 2021 | Medical student education through flipped learning and virtual rotations in radiation oncology during the COVID-19 pandemic: a cross sectional research
| RADIATION ONCOLOGY |
| 2021 | Development of a Margin Determination Framework for Tumor-Tracking Radiation Therapy With Intraoperatively Implanted Fiducial Markers
| FRONTIERS IN ONCOLOGY |
| 2021 | Efficacy of Whole-Ventricular Radiotherapy in Patients Undergoing Maximal Tumor Resection for Glioblastomas Involving the Ventricle
| FRONTIERS IN ONCOLOGY |
| 2021 | Risk of Cardiac Disease in Patients With Breast Cancer: Impact of Patient-Specific Factors and Individual Heart Dose From Three-Dimensional Radiation Therapy Planning | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
| 2021 | Assessment of radiation-induced otitis media in patients with parotid gland malignancy | ACTA OTO-LARYNGOLOGICA |
| 2021 | Prediction of Immune-Checkpoint Blockade Monotherapy Response in Patients With Melanoma Based on Easily Accessible Clinical Indicators
| FRONTIERS IN ONCOLOGY |
| 2021 | Adaptive Natural Killer Cells Facilitate Effector Functions of Daratumumab in Multiple Myeloma | CLINICAL CANCER RESEARCH |
| 2021 | PD-1 blockade-unresponsive human tumor-infiltrating CD8 + T cells are marked by loss of CD28 expression and rescued by IL-15 | CELLULAR & MOLECULAR IMMUNOLOGY |
| 2021 | Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma | JOURNAL OF HEPATOLOGY |
| 2021 | Dynamic changes in circulating PD-1(+)CD8(+)T lymphocytes for predicting treatment response to PD-1 blockade in patients with non-small-cell lung cancer | EUROPEAN JOURNAL OF CANCER |
| 2020 | Immunological Characteristics of Hyperprogressive Disease in Patients with Non-small Cell Lung Cancer Treated with Anti-PD-1/PD-L1 Abs
| IMMUNE NETWORK |
| 2020 | Gene Expression Profiling Identifies Akt as a Target for Radiosensitization in Gastric Cancer Cells
| FRONTIERS IN ONCOLOGY |
| 2020 | Tumor Immune Microenvironment in Cancer Patients With Leukocytosis | CANCER IMMUNOLOGY IMMUNOTHERAPY |
| 2016 | Early hypopharyngeal cancer treated with different therapeutic approaches: a single-institution cohort analysis
| RADIATION ONCOLOGY JOURNAL |
| 2015 | De-escalation of the cumulative central radiation dose according to the tumor response can reduce rectal toxicity without compromising the treatment outcome in patients with uterine cervical cancer | GYNECOLOGIC ONCOLOGY |
